1. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients.
- Author
-
Wissmann G, Alvarez-Martinez MJ, Meshnick SR, Dihel AR, and Prolla JC
- Subjects
- AIDS-Related Opportunistic Infections drug therapy, AIDS-Related Opportunistic Infections prevention & control, Adult, Aged, Antifungal Agents pharmacology, Antifungal Agents therapeutic use, Brazil, Bronchoalveolar Lavage Fluid microbiology, Drug Combinations, Drug Resistance, Fungal, Female, Humans, Male, Middle Aged, Mutation, Pneumocystis carinii genetics, Pneumonia, Pneumocystis drug therapy, Pneumonia, Pneumocystis prevention & control, Polymerase Chain Reaction, Retrospective Studies, Sulfamethizole therapeutic use, Trimethoprim therapeutic use, Trimethoprim Resistance, AIDS-Related Opportunistic Infections microbiology, Acquired Immunodeficiency Syndrome complications, Dihydropteroate Synthase genetics, Pneumocystis carinii drug effects, Pneumocystis carinii enzymology, Pneumonia, Pneumocystis microbiology, Sulfamethizole pharmacology, Trimethoprim pharmacology
- Abstract
Several studies from developed countries have documented the association between trimethoprim-sulfamethoxazole prophylaxis failure and mutations in the Pneumocystis jirovecii gene coding for dihydropteroate synthase (DHPS). DNA was extracted from Giemsa-stained smears of 70 patients with P. jirovecii pneumonia seen in Porto Alegre, Brazil, from 1997 to 2004. Successful PCR amplification of the DHPS locus was obtained in 57 of 70 cases (81.4%), including five cases (8.7%) that had used sulfa prophylaxis. No DHPS gene mutations were seen. These results suggest that DHPS mutations are currently as rare in Brazil as in other developing countries.
- Published
- 2006
- Full Text
- View/download PDF